Chiun Y. Hsu

No. 7, Chung Shan South Road, 100
TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

Early Change in Subcutaneous Fat Attenuation on Follow-up CT Provides Prognostic Information Beyond AFP in Advanced Hepatocellular Carcinoma During Immunotherapy.

Early Change in Subcutaneous Fat Attenuation on Follow-up CT Provides Prognostic Information Beyond AFP in Advanced Hepatocellular Carcinoma During Immunotherapy.

Journal: Academic radiology

Published: April 18, 2026

Integrating Generative AI Into Clinical Reasoning Education for Medical Students: Mixed Methods Study.

Integrating Generative AI Into Clinical Reasoning Education for Medical Students: Mixed Methods Study.

Journal: JMIR medical education

Published: March 09, 2026

Reply to: "Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma".

Reply to: "Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma".

Journal: Journal of hepatology

Published: March 05, 2026

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Journal: Journal for immunotherapy of cancer

Published: February 09, 2026

A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validation.

A visualized nurse-led ePRO system for chemotherapy toxicity: Content design and validation.

Journal: International journal of medical informatics

Published: December 07, 2025

Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration"".

Reply to: "Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration"".

Journal: Journal of hepatology

Published: December 02, 2025

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers.

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers.

Journal: Future oncology (London, England)

Published: November 24, 2025

SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217).

SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217).

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 18, 2025

Evaluating physicians' teaching perspectives and demonstration of core competencies in clinical shadowing.

Evaluating physicians' teaching perspectives and demonstration of core competencies in clinical shadowing.

Journal: BMC medical education

Published: September 25, 2025

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.

Journal: Life sciences

Published: August 20, 2025

Engineered T-cell therapy for hepatocellular carcinoma: The dawn of precision immunotherapy?

Engineered T-cell therapy for hepatocellular carcinoma: The dawn of precision immunotherapy?

Journal: Journal of hepatology

Published: August 19, 2025

Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Journal: Molecular cancer

Published: June 23, 2025

Showing 1-12 of 121

Last Updated: 09/26/2026